ral adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 2005;14:1401-6. [III Shaw JV/, Johnson JA, Coons SJ. US valuation of the EQ-5D health sues: development and testing of the DI valuation model. Med Care 2005;43:203-20. [12] Fairbank JC, Py